{{Short description|US healthcare company}} {{Use American English|date=February 2026}} {{Redirect|McKesson|other uses|McKesson (disambiguation)}} {{Use mdy dates|date=February 2026}} {{Infobox company | name = McKesson Corporation | logo = McKesson logo.svg | image = | type = Public | traded_as = {{Unbulleted list| {{NYSE|MCK}} | S&P 500 component }} | founders = {{Unbulleted list| John McKesson | Charles M. Olcott }} | location = | hq_location_city = Irving, Texas | hq_location_country = US | key_people = {{Unbulleted list| Brian S. Tyler (CEO) | Donald Knauss (chairman) }} | industry = Healthcare | image_caption = McKesson Corporation's headquarters in Irving, Texas | former_names = {{Unbulleted list| Olcott (1828–1833) | Olcott & McKesson (1833–1853) | McKesson & Robbins (1853–1967) | McKessonHBOC (1999–2001) }} | products = {{Unbulleted list| Pharmaceuticals | Medical technology | Health care services }} | revenue = {{nowrap|{{increase}} {{US$|359 billion|link=yes}} (2025)}} | operating_income = {{increase}} {{US$|4.42 billion}} (2025) | net_income = {{increase}} {{US$|3.29 billion}} (2025) | assets = {{increase}} {{US$|75.1 billion}} (2025) | equity = {{decrease}} {{US$|-2.1 billion}} (2025) | num_employees = {{circa|45,000}} (2025) | homepage = {{URL|mckesson.com|McKesson.com}} | subsid = {{Unbulleted list| Health Mart | Uniprix }} | foundation = {{start date and age|1833}} in New York City, US | footnotes = Financials {{as of|2025|03|31|lc=y|df=US}}<ref>{{Cite web |url=https://www.sec.gov/ix?doc=/Archives/edgar/data/0000927653/000092765325000036/mck-20250331.htm |title=FY 2025 Annual Report (Form 10-K) |date=May 9, 2025 |publisher=U.S. Securities and Exchange Commission |pages=9, 60, 62}}</ref> }} '''McKesson Corporation''' is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees.<ref>{{Cite web |title=McKesson {{!}} MCK Stock Price, Company Overview & News |url=https://www.forbes.com/companies/mckesson/ |access-date=January 15, 2025 |website=Forbes |language=en}}</ref><ref>{{Cite web |title=Key Facts About McKesson {{!}} Health Care Services Leader {{!}} McKesson |url=https://www.mckesson.com/about-mckesson/key-facts/ |access-date=January 15, 2025 |website=www.mckesson.com |language=en}}</ref> With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags.<ref>{{cite magazine |url=http://harpers.org/archive/2009/02/sick-in-the-head/ |title=Sick in the Head |first=Luke |last=Mitchell |date=February 1, 2009 |magazine=Harper's Magazine |access-date=April 24, 2017 |archive-url=https://web.archive.org/web/20170525082422/https://harpers.org/archive/2009/02/sick-in-the-head/ |archive-date=May 25, 2017 |url-status=live}}</ref> The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.<ref name=":2">{{Cite web|last=Leggate |first=James |date=July 22, 2020 |title=What is McKesson? |url=https://www.foxbusiness.com/markets/what-is-mckesson|access-date=May 6, 2021 |website=FOXBusiness |language=en-US}}</ref>
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.<ref name="biospace.com">{{cite web |last1=Terry |first1=Mark |title=Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution |url=https://www.biospace.com/article/operation-warp-speed-selects-mckesson-for-covid-19-vaccine-distribution/ |website=BioSpace |date=August 17, 2020 |access-date=December 10, 2021}}</ref><ref name="Covid-19 Vaccine Background">{{cite web |title=McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS |url=https://s24.q4cdn.com/128197368/files/doc_financials/2022/q4/MCK-Q4-FY22-Earnings-Release_FINAL.pdf |website=McKesson Investor Relations |access-date=May 5, 2021}}</ref>
==History==
===19th century=== McKesson was founded in 1828 in New York City as '''Charles M. Olcott''' by Charles M. Olcott.<ref name=":3">{{Cite book |last=Olcott |first=Mary Louisa Beatrice |title=The Olcotts and Their Kindred: From Anglo-Saxon Times, Through Róncesvalles to Gettsburg and After |date=1956 |publisher=National Americana Publications |pages=130 |language=en}}</ref> It was later renamed '''Olcott, McKesson & Co.''' and '''John McKesson''' in 1833,<ref>McKesson & Robbins, ''First Aid In Emergencies'', 1930, p. 63.</ref> the business began as an importer and wholesaler of botanical drugs.<ref name=":3" /> A third partner, Daniel Robbins, who joined the enterprise as it grew, and who previously "was an assistant to the original partners",<ref>{{cite news |newspaper=East Bay Times |url=https://www.eastbaytimes.com/2010/01/22/san-franciscos-mckesson-the-largest-company-no-one-has-heard-of |title=San Francisco's McKesson: 'The largest company no one has heard of' |author=David Morrell |date=January 22, 2010 |url-status=live |archive-url=https://web.archive.org/web/20220713102331/https://www.eastbaytimes.com/2010/01/22/san-franciscos-mckesson-the-largest-company-no-one-has-heard-of/ |archive-date= July 13, 2022 }}</ref> was the "Robbins" when the company was renamed '''McKesson & Robbins''' following Olcott's death in 1853.
===20th century=== {{Further|McKesson and Robbins scandal}} In 1938, the company was involved in the McKesson and Robbins scandal under CEO Phillip Musica. It was one of the most notorious business and accounting scandals of the 20th century, a watershed event that led to major changes in American auditing standards and securities regulations after being exposed in 1938. It was found that one fourth of the $86,556,270 assets of the company was just figures recorded to keep McKesson looking profitable while Musica, who was posing as F. Donald Coster, and his brothers stole the funds.<ref>{{Cite journal |date=July 24, 1939 |title=Business: New Accounting |url=https://time.com/archive/6769279/business-new-accounting/ |journal=Time}}</ref> The company was able to weather the crisis after an equity receivership.<ref>{{Cite news |date=December 16, 1938 |title=Coster's Dual Existence Unique In the Criminal History of City; Pardoned From Prison, He Gave Himself New Parents, New Social Background and an Impressive Fake Biography in 'Who's Who' COSTER REVEALED AS AN EX-CONVICT Big Enough for Wall Street" Activity of Unit a Mystery Many Rumors on Dealings Hair Goods Case Recalled |url=https://www.nytimes.com/1938/12/16/archives/costers-dual-existence-unique-in-the-criminal-history-of-city.html |access-date=January 26, 2026 |work=The New York Times}}</ref><ref>Baldwin, W. H., & Beach, B. S. (1940). McKesson & Robbins: A Study in Confidence. ''The Public Opinion Quarterly'', ''4''(2), pp. 305–310.</ref>
In 1967, Foremost Dairies, a company founded by James Cash Penney, which was headquartered in San Francisco since 1954, acquired McKesson & Robbins in a hostile takeover<ref>[''Everybody's Business'' 1st edition (Milton Moskowitz, Michael Katz, Robert Levering, editors) Harper & Row, 1980 page 815]</ref> to form Foremost-McKesson Inc.<ref>{{cite web|url=https://www.mckesson.com/about-mckesson/our-history/|title=History of McKesson Corporation|work=mckesson.com|access-date=April 20, 2015|archive-url=https://web.archive.org/web/20150424035134/http://www.mckesson.com/about-mckesson/our-history/|archive-date=April 24, 2015|url-status=live}}</ref> The Foremost dairy operations were sold in 1982 and the name changed to ''McKesson Corporation'' but headquarters remained in San Francisco.<ref>{{Cite news| issn = 0362-4331| last = Ap| title = Foremost Dairies| work = The New York Times| access-date = March 10, 2019| date = September 3, 1982| url = https://www.nytimes.com/1982/09/03/business/foremost-dairies.html| archive-url = https://web.archive.org/web/20150524103132/http://www.nytimes.com/1982/09/03/business/foremost-dairies.html| archive-date = May 24, 2015| url-status = live}}</ref>
In 1999, McKesson acquired medical information systems firm HBO & Company (HBOC).<ref>{{Cite news|last=Gomes|first=Lee|date=October 19, 1998|title=McKesson Agrees to Acquire HBO & Co. for $14.46 Billion|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/SB908750143221909000|access-date=September 3, 2020|issn=0099-9660}}</ref><ref name=":1">{{Cite web|date=September 28, 2000|title=Former executives of HBO & Co. indicted on accounting fraud charges - Sep. 28, 2000|url=https://money.cnn.com/2000/09/28/companies/mckesson/|archive-url=https://web.archive.org/web/20220407101427/https://money.cnn.com/2000/09/28/companies/mckesson/|url-status=dead|archive-date=April 7, 2022|access-date=September 3, 2020|website=CNN}}</ref> The combined firm operated as '''McKessonHBOC''' for two years.<ref>{{Cite web|date=July 26, 2001|title=McKesson Drops HBOC From Name|url=https://www.latimes.com/archives/la-xpm-2001-jul-26-fi-26746-story.html|access-date=September 3, 2020|website=Los Angeles Times|language=en-US}}</ref> Accounting irregularities at HBOC reduced the company's share price by half and resulted in the dismissal and prosecution of many HBOC executives.<ref name=":1" />
===21st century=== [[File:McKesson HQ.jpg|thumb|upright|The company's former headquarters at McKesson Plaza in San Francisco; in 2019, it relocated to Irving, Texas]]
In 2001, the company's name reverted to '''McKesson'''.<ref>{{cite news|author=Milt Freudenheim|title=McKesson Agrees to Pay $960 Million in Fraud Suit|newspaper=The New York Times|date=January 13, 2005|url=https://www.nytimes.com/2005/01/13/business/13settle.html|access-date=March 17, 2008|archive-url=https://web.archive.org/web/20130531090012/http://www.nytimes.com/2005/01/13/business/13settle.html|archive-date=May 31, 2013|url-status=live}}</ref> In the early 21st century, McKesson increased its market in medical technology through acquisitions, including Per Se Technologies and RelayHealth in 2006<ref>{{Cite web|date=November 7, 2006|title=McKesson to acquire Per-Se Technologies|url=https://www.latimes.com/archives/la-xpm-2006-nov-07-fi-mckesson7-story.html|access-date=September 3, 2020|website=Los Angeles Times|language=en-US}}</ref><ref>{{Cite web|date=June 12, 2006|title=McKesson acquires RelayHealth|url=https://www.modernhealthcare.com/article/20060612/PREMIUM/606120313/mckesson-acquires-relayhealth|access-date=September 3, 2020|website=Modern Healthcare|language=en}}</ref> and Practice Partner in 2007.<ref>{{Cite web|date=February 28, 2007|title=McKesson acquires Practice Partner|url=https://www.modernhealthcare.com/article/20070228/PREMIUM/70228002/mckesson-acquires-practice-partner|access-date=September 3, 2020|website=Modern Healthcare|language=en}}</ref>
On January 6, 2006, McKesson acquired NDCHealth Corporation.<ref>{{Cite web |last=Urbanowicz |first=Nicole |date=November 6, 2006 |title=2nd UPDATE: McKesson To Buy Per-Se For $1.8 Billion, $28/Share - Nov. 6, 2006 |url=https://money.cnn.com/news/newsfeeds/articles/djf500/200611061453DOWJONESDJONLINE000512_FORTUNE5.htm |archive-url=https://web.archive.org/web/20240725194006/https://money.cnn.com/news/newsfeeds/articles/djf500/200611061453DOWJONESDJONLINE000512_FORTUNE5.htm |url-status=dead |archive-date=July 25, 2024 |access-date=July 25, 2024 |website=money.cnn.com |publisher=DOW JONES NEWSWIRES}}</ref>
In 2010, McKesson acquired the oncology and physician services company US Oncology, Inc. for $2.16 billion, which was integrated into the McKesson Specialty Health business.<ref>{{Cite web|last=Whelan|first=David|title=Why Did McKesson Buy U.S. Oncology?|url=https://www.forbes.com/sites/davidwhelan/2010/11/01/why-did-mckesson-buy-u-s-oncology/ |access-date=September 3, 2020 |website=Forbes |language=en}}</ref>
In April 2012, McKesson agreed to pay the United States $190M to settle allegations that it had inflated prices and overbilled Medicaid.<ref>{{Cite web|date=April 26, 2012|title=McKesson Corp. Pays U.S. More Than $190 Million to Resolve False Claims Act Allegations|url=https://www.justice.gov/opa/pr/mckesson-corp-pays-us-more-190-million-resolve-false-claims-act-allegations|access-date=February 21, 2022|website=www.justice.gov|language=en}}</ref> Three months later, in July 2012, McKesson agreed to pay California and 28 other states $151M to settle allegations that it had inflated prices and overbilled Medicaid.<ref>{{Cite web|date=July 26, 2012|title=Attorney General Kamala D. Harris Recovers $23.5 Million in Settlement with McKesson Over Inflated Prescription Drug Prices|url=https://oag.ca.gov/news/press-releases/attorney-general-kamala-d-harris-recovers-235-million-settlement-mckesson-over|access-date=February 21, 2022|website=State of California - Department of Justice - Office of the Attorney General|language=en}}</ref>
On June 24, 2013, ''The Wall Street Journal'' reported that McKesson Chairman and CEO John Hammergren's pension benefits of $159 million had set a record for "the largest pension on file for a current executive of a public company, and almost certainly the largest ever in corporate America".<ref>{{cite news|url=https://www.wsj.com/articles/SB10001424127887323998604578565491579124154|title=McKesson CEO Is Due $159 Million Pension|author=Mark Maremont|date=June 25, 2013|newspaper=The Wall Street Journal|access-date=April 20, 2015|archive-url=https://web.archive.org/web/20150427150632/http://www.wsj.com/articles/SB10001424127887323998604578565491579124154|archive-date=April 27, 2015|url-status=live}}</ref>
In 2013, PSS World Medical was acquired.
In 2014, McKesson acquired Celesio to become one of the world's largest healthcare companies, with over $179 billion in annual revenue.<ref>{{Cite web|url=https://www.mckesson.com/about-mckesson/newsroom/press-releases/2013/mckesson-launches-public-takeover-offer-for-celesio/|title=McKesson Launches Public Takeover Offer for Celesio {{!}} McKesson|website=www.mckesson.com |access-date=January 21, 2019 |archive-url=https://web.archive.org/web/20180807063855/https://www.mckesson.com/about-mckesson/newsroom/press-releases/2013/mckesson-launches-public-takeover-offer-for-celesio/|archive-date=August 7, 2018|url-status=live}}</ref>
In June 2016, McKesson announced plans to merge its IT business with Change Healthcare.<ref>{{Cite web|last=Kennedy|first=Eleanor|date=June 28, 2016|title=Change Healthcare merger to create health IT giant|url=https://www.bizjournals.com/nashville/news/2016/06/28/change-healthcare-merger-to-create-health-it-giant.html|website=Nashville Business Journal}}</ref>
In 2017, McKesson was involved in many lawsuits against the state of Arkansas over the supply of vecuronium bromide. McKesson was under contract by Pfizer not to sell to any correctional facility that authorized and carried out capital punishment.<ref>{{cite news|url=https://www.theguardian.com/commentisfree/2017/apr/16/arkansas-mass-executions-easter-monday-must-be-stopped|title=Can big pharma stop the Arkansas mass executions?|date=April 16, 2017|work=The Guardian|access-date=April 21, 2017|archive-url=https://web.archive.org/web/20170421194915/https://www.theguardian.com/commentisfree/2017/apr/16/arkansas-mass-executions-easter-monday-must-be-stopped|archive-date=April 21, 2017|url-status=live}}</ref><ref>[http://www.cbsnews.com/news/supplier-drug-sold-to-arkansas-not-intended-for-executions/ Supplier: Drug sold to Arkansas not intended for executions] {{Webarchive|url=https://web.archive.org/web/20170422033433/http://www.cbsnews.com/news/supplier-drug-sold-to-arkansas-not-intended-for-executions/ |date=April 22, 2017}} {{!}} CBS News</ref>
In November 2018, the company announced it would relocate its headquarters from San Francisco to Irving, Texas, effective April 1, 2019.<ref>{{cite news |title=McKesson, nation's sixth largest company, is moving corporate HQ from California to Irving |url=https://www.dallasnews.com/business/health-care/2018/11/30/medical-industry-giant-mckesson-move-headquarters-irving |access-date=December 4, 2018 |work=Dallas News |date=November 30, 2018 |archive-url=https://web.archive.org/web/20181204102133/https://www.dallasnews.com/business/health-care/2018/11/30/medical-industry-giant-mckesson-move-headquarters-irving |archive-date=December 4, 2018 |url-status=live}}</ref><ref>{{cite web|url=https://www.mckesson.com/about-mckesson/newsroom/press-releases/2019/brian-tyler-new-mckesson-ceo/|title=Brian Tyler Becomes McKesson's New CEO - McKesson|website=www.mckesson.com|access-date=April 12, 2019|archive-url=https://web.archive.org/web/20190412205619/https://www.mckesson.com/about-mckesson/newsroom/press-releases/2019/brian-tyler-new-mckesson-ceo/|archive-date=April 12, 2019|url-status=live}}</ref> Also in April 2019, Brian Tyler took over as CEO of the company.<ref>{{Cite web|last=Schneider|first=Rob|date=December 6, 2019|title='Don't Debate It For 40 Years, Do It' Brian Tyler, McKesson|url=https://www.bizjournals.com/dallas/news/2019/12/06/i-get-paid-to-make-the-right-decisions-for-the.html|website=Dallas Business Journal}}</ref>
In February 2020, McKesson Corp announced that it would part ways with Change Healthcare.<ref name=":0" /> McKesson gave up its ownership in the company and its three seats on the company's board of directors.<ref name=":0">{{Cite web|last=Stinnett|first=Joel|date=February 5, 2020|title=Three years after merger, McKesson to part ways with Change Healthcare|url=https://www.bizjournals.com/nashville/news/2020/02/05/three-years-after-merger-mckesson-to-part-ways.html?ana=yahoo&yptr=yahoo|access-date=March 3, 2020|website=Nashville Business Journal}}</ref>
In February 2025, the McKesson Corporation signed a definitive agreement to acquire 80% interest in PRISM Vision Holdings.<ref>{{cite web|url=https://www.mckesson.com/about-mckesson/newsroom/press-releases/2025/mckesson-advances-specialty-leadership--signs-agreement-to-acquire-controlling-interest-in-prism-vision-holdings-llc/|title=McKesson Advances Specialty Leadership, Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings LLC|accessdate=March 19, 2025}}</ref>
====Opioid epidemic==== {{Further|Opioid epidemic}} In 2008, McKesson paid $13 million in fines for failing to report large orders of hydrocodone.<ref>{{cite news |author=Bill Whittaker |title=Whistleblowers: DEA attorneys went easy on McKesson, the country's largest drug distributor|url=https://www.cbsnews.com/news/whistleblowers-dea-attorneys-went-easy-on-mckesson-the-countrys-largest-drug-distributor |access-date=December 24, 2017 |agency=CBS News |date=December 17, 2017 |language=en |archive-url=https://web.archive.org/web/20171224214722/https://www.cbsnews.com/news/whistleblowers-dea-attorneys-went-easy-on-mckesson-the-countrys-largest-drug-distributor |archive-date=December 24, 2017 |url-status=live}}</ref>
In January 2017, McKesson agreed to pay a $150 million civil penalty for alleged similar violations of the Controlled Substances Act regarding the distribution of opioids <ref name="McKesson-Corp-Jun-2017-DEF-14A">{{cite web |url=http://pdf.secdatabase.com/672/0001193125-17-205237.pdf |title=McKesson Corp, Form DEF 14A, Filing Date Jun 16, 2017 |publisher=SECdatabase.com |access-date=April 23, 2018 |archive-url=https://web.archive.org/web/20180424135832/http://pdf.secdatabase.com/672/0001193125-17-205237.pdf |archive-date=April 24, 2018 |url-status=live}}</ref> and another $150M to settle allegations that it had not done enough to track and stop suspicious opioid sales.<ref>{{Cite web|date=January 17, 2017|title=McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs|url=https://www.justice.gov/opa/pr/mckesson-agrees-pay-record-150-million-settlement-failure-report-suspicious-orders|access-date=February 21, 2022|website=www.justice.gov|language=en}}</ref> The agreement also obligated McKesson to suspend all sales of controlled substances from its distribution centers in Colorado, Florida, Ohio, and Michigan for multiple years.
In May 2020, Attorney General of Oklahoma Michael J. Hunter sued McKesson in Bryan County District Court, alleging that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and AmerisourceBergen, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."<ref>{{Cite web |title=Attorney General Hunter Refiles Lawsuits against Three Leading Opioid Distributors {{!}} Oklahoma Attorney General |url=https://oag.ok.gov/articles/attorney-general-hunter-refiles-lawsuits-against-three-leading-opioid-distributors |access-date=March 12, 2022 |website=oag.ok.gov}}</ref>
In January 2022, McKesson, AmerisourceBergen, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them.<ref>{{Cite news|last=Raymond|first=Nate|date=January 27, 2022|title=Most U.S. local governments opt to join $26 bln opioid settlement|language=en|work=Reuters|url=https://www.reuters.com/world/us/most-us-local-governments-opt-join-26-bln-opioid-settlement-2022-01-26/|access-date=February 21, 2022}}</ref> Had the states gone to court, the companies could have faced up to $95 billion in penalties.<ref>{{Cite news|last=Raymond|first=Nate|date=November 16, 2021|title=Washington state, in $95 billion opioid trial, blames drug distributors for crisis|language=en|work=Reuters|url=https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/|access-date=February 21, 2022}}</ref>
====COVID-19 pandemic==== In August 2020, during the COVID-19 pandemic, the CDC and HHS selected McKesson as the US government's centralized distributor for COVID-19 vaccine doses and ancillary supply kits under Operation Warp Speed.<ref name="Bloomberg LP">{{cite news |last1=Raimonde |first1=Olivia |title=McKesson to Distribute Virus Vaccine Under Existing U.S. Pact |url=https://www.bloomberg.com/news/articles/2020-08-14/trump-announced-deal-with-mckesson-for-vaccine-distribution |access-date=December 10, 2021 |publisher=Bloomberg LP |date=August 14, 2020}}</ref><ref name="biospace.com" /> The company has played a key role in distributing the Moderna and Johnson & Johnson vaccines while also distributing ancillary supply kits for these as well as for the Pfizer–BioNTech vaccine across the US (in addition to supporting the US government in efforts to send doses and kits abroad).<ref>{{cite web |title=A Look Into Our COVID-19 Vaccine Ancillary Supply Kit Operation |url=https://www.mckesson.com/Our-Stories/COVID-19-Vaccine-Ancillary-Supply-Kit-Operation/ |publisher=McKesson Corp}}</ref><ref name="Covid-19 Vaccine Background" />
==Finances== For the fiscal year 2023, McKesson reported earnings of US$3.56 billion on revenue of US$276.711 billion.<ref>{{Cite web|url=https://investor.mckesson.com/reports|title=Financial Information {{!}} McKesson Investor Relations|website=investor.mckesson.com|language=en |access-date=November 7, 2018 |archive-url=https://web.archive.org/web/20190114210700/https://investor.mckesson.com/reports|archive-date=January 14, 2019|url-status=live}}</ref> {{As of|2023|post=,}} McKesson was the nation's largest health care company and the ninth-largest company by total revenue on the ''Fortune'' 500.<ref>{{Cite web|url=http://fortune.com/fortune500/list/|title=Fortune 500 Companies 2018: Who Made the List|website=Fortune|language=en-US|access-date=November 9, 2018|archive-url=https://web.archive.org/web/20181110190356/http://fortune.com/fortune500/list/|archive-date=November 10, 2018|url-status=live}}</ref> {| class="wikitable" style="text-align:right;" |- !scope="col"| Year !scope="col"| Revenue<br />(US$M) !scope="col"| Net income<br />(US$M) !scope="col"| Total assets<br />(US$M) !scope="col"| Price per share<br />(US$) !scope="col"| Employees |- !scope="row"| 2005 | 79,096 | −157 | 18,775 | 36.41 | |- !scope="row"| 2006 | 86,983 | 751 | 20,961 | 44.00 | |- !scope="row"| 2007 | 92,977 | 913 | 23,943 | 51.66 | |- !scope="row"| 2008 | 101,703 | 990 | 24,603 | 45.79 | |- !scope="row"| 2009 | 106,632 | 823 | 25,267 | 43.23 | |- !scope="row"| 2010 | 108,702 | 1,263 | 28,189 | 57.52 | 32,500 |- !scope="row"| 2011 | 112,084 | 1,202 | 30,886 | 71.40 | 32,500 |- !scope="row"| 2012 | 122,321 | 1,403 | 33,093 | 80.91 | 36,400 |- !scope="row"| 2013 | 122,196 | 1,338 | 34,786 | 113.59 | 43,500 |- !scope="row"| 2014 | 137,392 | 1,263 | 51,759 | 173.29 | 42,800 |- !scope="row"| 2015 | 179,045 | 1,476 | 53,870 | 198.26 | 70,400 |- !scope="row"| 2016 | 190,884 | 2,258 | 56,523 | 156.90 | 68,000 |- !scope="row"| 2017 | 198,533 | 5,070 | 60,969 | 141.87 | 78,000 |- !scope="row"| 2018 | 208,357 | 67 | 60,381 | 132.29 | 78,000 |- !scope="row"| 2019 | 214,319 | 34 | 59,672 | 127.96 | 80,000 |- ! 2020 | 231,051 | 900 | 61,247 | 148.34 | 80,000 |- ! 2021 | 238,228 | −4,539 | 65,015 | 195.88 | 76,000 |- ! 2022 | 263,966 | 1,114 | 63,298 | 325.94 | 75,000 |- ! 2023 | 276,711 | 3,560 | 62,320 | 405.02 | 51,000 |}
==Divisions==
===McKesson Provider Technologies=== McKesson Provider Technologies is the retail name for McKesson Technology Solutions; the software development division of McKesson. Their customer base in the United States includes 50% of all health systems, 20% of all physician practices, 25% of home care agencies, and 77% of health systems with more than 200 beds.
On June 20, 2005, McKesson Provider Technologies acquired Medcon, Ltd., an Israeli company which provides web-based cardiac image and information management solutions for heart centers, that includes: diagnostic digital image management, archiving, procedure reporting, and workflow management.<ref>[http://www.businesswire.com/news/home/20050815005419/en/McKesson-Completes-Acquisition-Medcon-Ltd. McKesson Completes Acquisition of Medcon Ltd. | Business Wire] {{Webarchive|url=https://web.archive.org/web/20131203003705/http://www.businesswire.com/news/home/20050815005419/en/McKesson-Completes-Acquisition-Medcon-Ltd. |date=December 3, 2013}} August 15, 2005</ref>
In October 2013, McKesson agreed to buy a 50% stake in Germany-based Celesio for $8.3 billion.<ref>{{cite news | url=https://www.reuters.com/article/us-celesio-mckesson-deal-idUSBRE99N05N20131024 |title=McKesson $8.3 billion deal for drugs trader Celesio to create market leader |last=Burger |first=Ludwig |work=Reuters |date=October 24, 2013 |access-date=July 1, 2017 |archive-url=https://web.archive.org/web/20150924190214/http://www.reuters.com/article/2013/10/24/us-celesio-mckesson-deal-idUSBRE99N05N20131024 |archive-date=September 24, 2015 |url-status=live}}</ref>
===McKesson Medical Supplies and Equipment=== [[File:McKesson Medical-Surgical Corporate campus.jpg|alt=McKesson Medical-Surgical Corporate campus in Richmond, Virginia|thumb|McKesson Medical-Surgical Corporate campus in Richmond, Virginia]] McKesson Medical-Surgical (MMS) offers a large selection of national healthcare brands, along with McKesson's exclusive brand of medical products.
Their online medical supply ordering platform serves the needs of physician offices, surgery centers, home health agencies, DMEs, labs, and long-term-care facilities.<ref>{{Cite news|url=https://www.mckesson.com/medical-supplies/|title=McKesson Medical Supplies and Equipment |access-date=March 1, 2018 |language=en |archive-url=https://web.archive.org/web/20190121233014/https://www.mckesson.com/medical-supplies/ |archive-date=January 21, 2019 |url-status=live}}</ref>
In 2015, McKesson Medical-Surgical opened its new headquarters in Richmond, Virginia.<ref>{{Cite news|url=http://www.richmond.com/business/local/mckesson-medical-surgical-opens-its-new-headquarters/article_4ca9307c-b39a-5b9a-9ce6-e7e60b4e1567.html|title=McKesson Medical-Surgical opens its new headquarters |last=Gilligan |first=Gregory J. |work=Richmond Times-Dispatch |access-date=January 12, 2018 |language=en}}</ref>
In May of 2025, McKesson announced it was planning to spin off its medical-surgical supplies unit into an independent company.<ref>{{Cite news |title=McKesson to spin off surgical supplies unit, forecasts strong annual profit |url=https://www.reuters.com/business/healthcare-pharmaceuticals/mckesson-spin-off-surgical-supplies-unit-forecasts-strong-annual-profit-2025-05-08/ |archive-url=https://web.archive.org/web/20250515135411/https://www.reuters.com/business/healthcare-pharmaceuticals/mckesson-spin-off-surgical-supplies-unit-forecasts-strong-annual-profit-2025-05-08/ |archive-date=May 15, 2025 |access-date=2026-02-20 |work=Reuters |language=en-US |url-status=live }}</ref>
===Health Mart pharmacy franchise=== {{Further|Health Mart}} [[File:McKesson Pharmacy Systems Livonia Michigan.JPG|thumb|McKesson Pharmacy Systems in Livonia, Michigan]]
Health Mart, a network of over 4,000<ref>{{cite web |url=http://healthmart.com/faqs|title=Health Mart Pharmacy of the Year Spotlight|publisher=healthmart.com}}</ref> independently owned and operated pharmacies, is a wholly owned subsidiary of McKesson Corporation, which owns the name "Health Mart". McKesson acquired Health Mart owner FoxMeyer in October 1996.<ref name="McKesson-Corp-Nov-1996-8-K">{{cite web |url=http://edgar.secdatabase.com/2922/101287096000715/filing-main.htm |title=McKesson Corp, Form 8-K, Current Report, Filing Date Nov 22, 1996 |publisher=secdatabase.com |access-date=April 23, 2018 |archive-url=https://web.archive.org/web/20180424135552/http://edgar.secdatabase.com/2922/101287096000715/filing-main.htm |archive-date=April 24, 2018 |url-status=live}}</ref>
===Former divisions=== '''Mosswood Wine Company'''
McKesson operated the Mosswood Wine Company from 1978 until 1987 when the division was sold to maintain its focus on pharmaceuticals. The division was founded and run by wine writer Gerald Asher.<ref>{{cite web |url=http://theblendblog.com/wordpress/?p=3068 |title= The Stout Report: Eggs Florentine, Gavi and Breakfast with Gerald Asher|website=theblendblog.com |archive-url=https://web.archive.org/web/20130601065507/http://theblendblog.com/wordpress/?p=3068 |archive-date=June 1, 2013}}</ref>
====NDCHealth (Relay Health)==== '''NDC''' (from the initials of its former identity as National Data Corporation) became NDC-Health Corp in 2001 following the spin-off of its payments division, Global Payments, in 2000.<ref>{{Cite web|date=October 30, 2001|title=National Data Corp. changes name to NDCHealth Corp|url=https://www.bizjournals.com/atlanta/stories/2001/10/29/daily25.html|access-date=June 24, 2020|website=Atlanta Business Chronicle}}</ref> NDCHealth was acquired by McKesson in 2007 through the purchase of Per-Se Technologies at which time it began doing business as RelayHealth in 2007.<!--- fix that National Data Corporation links to McKesson Corporation YET .. the latter article does not even mention it ONCE -->
==International==
===McKesson Canada=== thumb|McKesson Canada
In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services from Provigo. In 2002, the McKesson Canada name was adopted. McKesson Canada is a wholly owned subsidiary of McKesson Corporation. It includes various business units: McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions, and McKesson Information Solutions.
In 2012, McKesson agreed to purchase Canadian pharmacy chains IDA, Guardian Pharmacy, and The Medicine Shoppe from the Katz Group of Companies for $920 million.<ref>{{cite web |title=Katz Group to sell part of business to U.S. firm |url=https://www.cbc.ca/news/canada/edmonton/katz-group-to-sell-part-of-business-to-u-s-firm-1.1130784 |website=CBC News |access-date=March 21, 2024 |archive-url=https://web.archive.org/web/20240321012657/https://www.cbc.ca/news/canada/edmonton/katz-group-to-sell-part-of-business-to-u-s-firm-1.1130784 |archive-date=March 21, 2024 |date=January 30, 2012 |url-status=live}}</ref>
In March 2016, McKesson agreed to purchase Canadian pharmacy chain Rexall from the Katz Group of Companies for $3 billion.<ref>{{cite news |first=Marina |last=Strauss |date=March 2, 2016 |url=https://www.theglobeandmail.com/report-on-business/mckesson-to-acquire-rexall-drugstore-chain-in-3-billion-deal/article28994105/ |title=Rexall takeover shakes up Canada's drugstore industry |publisher=The Globe and Mail |access-date=September 4, 2017 |archive-url=https://web.archive.org/web/20170826064311/https://www.theglobeandmail.com/report-on-business/mckesson-to-acquire-rexall-drugstore-chain-in-3-billion-deal/article28994105/ |archive-date=August 26, 2017 |url-status=live}}</ref> The deal was finalized in December 2016 following approval received under the Investment Canada Act.<ref>{{Cite web|url=https://investor.mckesson.com/press-release/mckesson-completes-acquisition-rexall-health-and-appoints-domenic-pilla-ceo-mckesson-c|title=McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada {{!}} McKesson Investor Relations|website=investor.mckesson.com|language=en|access-date=July 17, 2018|archive-url=https://web.archive.org/web/20190121232455/https://investor.mckesson.com/press-release/mckesson-completes-acquisition-rexall-health-and-appoints-domenic-pilla-ceo-mckesson-c|archive-date=January 21, 2019|url-status=live}}</ref>
On April 12, 2017, it was announced that McKesson Canada reached a deal to acquire 330 Uniprix pharmacies.<ref>{{Cite news |url=https://montrealgazette.com/business/mckesson-canada-reaches-deal-to-acquire-330-uniprix-pharmacies |title=McKesson Canada reaches deal to acquire 330 Uniprix pharmacies |work=Montreal Gazette |agency=The Canadian Press |date=April 12, 2017 |access-date=June 16, 2024}}</ref>
In May 2018, McKesson Canada closed 40 Rexall locations in Ontario and Western Canada.<ref>{{Cite news|url=https://globalnews.ca/news/4244322/rexall-closing-downtown-london/ |title=Rexall closing after less than 5 years in London's downtown core|work=980 CFPL |access-date=July 17, 2018 |language=en |archive-url=https://web.archive.org/web/20180717100719/https://globalnews.ca/news/4244322/rexall-closing-downtown-london/ |archive-date=July 17, 2018 |url-status=live}}</ref>
===United Kingdom=== In the United Kingdom, McKesson, operating as McKesson Information Solutions UK Ltd, was a provider of information technology services to the healthcare industry. In addition to numerous clinical software systems and finance and procurement services, McKesson also was responsible for developing the Electronic Staff Record system for the National Health Service which provided an integrated payroll system for NHS's 1.3 million staff, making it the world's largest single payroll IT system. McKesson Shared Services also provided payroll services for over 20 NHS Trusts, paying over 100,000 NHS members.
McKesson's United Kingdom base was in Warwick with data centers in Newcastle upon Tyne and Brent Cross and offices in Sheffield, Bangor, Glasgow and Vauxhall, London. Across the United Kingdom, it employed over 500 people.
In 2014, McKesson sold most of their healthcare software business to the private equity firm Symphony Technology Group and indicated also that they would not be re-bidding for the Electronic Staff Record contract.<ref>{{cite news| url=http://www.ehi.co.uk/news/EHI/8571/mckesson-uk-put-up-for-sale| title=McKesson UK put up for sale| author=Jon Hoeksma| publisher=ehiNEWS| date=May 8, 2013| access-date=March 26, 2015| archive-url=https://web.archive.org/web/20150403232802/http://www.ehi.co.uk/news/ehi/8571/mckesson-uk-put-up-for-sale| archive-date=April 3, 2015| url-status=live}}</ref><ref>{{cite news| url=http://www.ehi.co.uk/news/EHI/9443/symphony-buys-mckesson-uk-health-ops| title=Symphony buys McKesson UK health ops| author=Jon Hoeksma| publisher=ehiNEWS| date=June 2, 2014| access-date=March 26, 2015| archive-url=https://web.archive.org/web/20150402092743/http://www.ehi.co.uk/news/EHI/9443/symphony-buys-mckesson-uk-health-ops| archive-date=April 2, 2015| url-status=live}}</ref> This came after the company had posted significant year on year losses in revenue (16% in the 2012/13 financial year<ref>{{cite web |url=http://www.healthinvestor.co.uk/(X(1)A(0JAUFky2zwEkAAAAMGZjMTc1ZDQtMzI5NC00MzBhLWE2ZTgtYjUwZjQ4ZjU4NWYwrxyndF8aeAkx2iG8Q44n612N1kk1)S(y4wmhy55oua2h4u5zypm1a45))/ShowArticle.aspx?ID=3366 |title=Article: Symphony Technology Group snaps up McKesson divestments |website=HealthInvestor |access-date=January 2, 2016 |archive-url=https://web.archive.org/web/20150925061821/http://www.healthinvestor.co.uk/(X(1)A(0JAUFky2zwEkAAAAMGZjMTc1ZDQtMzI5NC00MzBhLWE2ZTgtYjUwZjQ4ZjU4NWYwrxyndF8aeAkx2iG8Q44n612N1kk1)S(y4wmhy55oua2h4u5zypm1a45))/ShowArticle.aspx?ID=3366 |archive-date=September 25, 2015 |url-status=live}}</ref>) after taking over a very successful British operation in 2011.<ref>{{cite web |url=http://histalk2.com/2011/03/03/mckesson-to-acquire-british-software-vendor-system-c/ |title=McKesson To Acquire British Software Vendor System C | HIStalk |website=Histalk2.com |date=March 3, 2011 |access-date=January 2, 2016 |archive-url=https://web.archive.org/web/20150923182507/http://histalk2.com/2011/03/03/mckesson-to-acquire-british-software-vendor-system-c/ |archive-date=September 23, 2015 |url-status=live}}</ref>
In April 2022, McKesson UK was acquired by the private equity company, Aurelius Group in a £477m deal. The companies acquired by Aurelius include LloydsPharmacy, and AAH Pharmaceuticals.<ref>{{Cite web |last=Craft |first=Mark |title=Aurelius Completes Acquisition Of LloydsPharmacy And AAH - KamCity |date=April 8, 2022 |url=https://www.kamcity.com/namnews/uk-and-ireland/healthbeauty/aurelius-completes-acquisition-of-lloydspharmacy-and-aah/ |access-date=April 8, 2022 |language=en-GB}}</ref>
===Australia and New Zealand=== In 2010, McKesson Asia-Pacific was acquired by Medibank Private Ltd.<ref>{{cite web|title=McKesson to Sell Its McKesson Asia-Pacific Business to Medibank Private Ltd.|url=http://www.mckesson.com/about-mckesson/newsroom/press-releases/2010/mckesson-to-sell-its-mckesson-asia-pacific-business-to-medibank-private-ltd/|access-date=March 30, 2016|archive-url=https://web.archive.org/web/20160413215713/http://www.mckesson.com/about-mckesson/newsroom/press-releases/2010/mckesson-to-sell-its-mckesson-asia-pacific-business-to-medibank-private-ltd/|archive-date=April 13, 2016|url-status=dead}}</ref><ref>{{cite web|title=Medibank finalises acquisition of McKesson Asia-Pacific|url=http://www.medibank.com.au/About-Us/Media-Centre-Details.aspx?news=419|access-date=March 30, 2016|archive-url=https://web.archive.org/web/20160408081416/http://www.medibank.com.au/About-Us/Media-Centre-Details.aspx?news=419|archive-date=April 8, 2016|url-status=live}}</ref>
McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November 2012.<ref name="computerworld.co.nz">{{cite web |url=http://www.computerworld.co.nz/article/545884/mckesson_nz_aims_growth_plans_add_staff_products/ |title=McKesson NZ aims for growth with plans to add staff and products - Computerworld New Zealand |publisher=Computerworld.co.nz |date=May 23, 2014 |access-date=July 30, 2015 |archive-url=https://web.archive.org/web/20150720210808/http://www.computerworld.co.nz/article/545884/mckesson_nz_aims_growth_plans_add_staff_products/ |archive-date=July 20, 2015 |url-status=live}}</ref> McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand. The majority of the District Health Boards in NZ use one or more of McKesson's Capacity Management solutions.
Christchurch in New Zealand, is one of McKesson's global Capacity Management R&D centers of excellence. All of McKesson's R&D for McKesson Capacity Planner is performed in New Zealand. The company employs approximately 40 team members across Australia and New Zealand, including general management, R&D, sales, services, and support employees.
McKesson Capacity Planne, formerly Emendo CapPlan, is used in more than 40 hospitals in Australia, New Zealand, Britain, Canada, and the US<ref>{{cite web |author=Tamlyn Stewart |url=http://www.stuff.co.nz/the-press/business/7921141/Pharma-giant-snaps-up-Emendo |title=Pharma giant snaps up Emendo |publisher=Stuff.co.nz |date=November 8, 2012 |access-date=July 30, 2015 |archive-url=https://web.archive.org/web/20150924171249/http://www.stuff.co.nz/the-press/business/7921141/Pharma-giant-snaps-up-Emendo |archive-date=September 24, 2015 |url-status=live}}</ref> to forecast future patient activity and help health systems to allocate resources efficiently and identify unnecessary costs.<ref name="computerworld.co.nz" /><ref>{{cite web |author=Tamlyn Stewart |url=http://www.stuff.co.nz/business/small-business/7918268/Fortune-500-firm-buys-Kiwi-tech-company |title=Fortune 500 firm buys Kiwi tech company |publisher=Stuff.co.nz |date=November 7, 2012 |access-date=July 30, 2015 |archive-url=https://web.archive.org/web/20150924134441/http://www.stuff.co.nz/business/small-business/7918268/Fortune-500-firm-buys-Kiwi-tech-company |archive-date=September 24, 2015 |url-status=live}}</ref>
===Germany=== On November 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE). WBA holds a 70 percent controlling equity interest in the joint venture and McKesson holds the remaining 30 percent interest.<ref name="mckesson.com">{{cite web |url=https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2020/Walgreens-Boots-Alliance-McKesson-Complete-Formation-German-Wholesale-Venture/ |title=Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture |website=Mckesson.com |date=November 2, 2020 |access-date=November 2, 2020}}</ref>
==See also== * ''Fortune'' 500 * Top 100 Contractors of the US federal government
==References== {{Reflist}}
==External links== * {{Official website|https://www.mckesson.com/}} {{Finance links | name = McKesson Corporation | symbol = MCK | sec_cik = 927653 | reuters = MKC.N | bloomberg = MKC:US | yahoo = MCK | google = MCK }} * [https://medicalbillingrcm.com/mckesson-corporation-overview/ McKesson Corporation: Company Overview & History]
{{Pharmaceutical companies of the United States}} {{S&P 500 companies}} {{Authority control|state=expanded}}
Category:McKesson Corporation Category:1833 establishments in New York (state) Category:American companies established in 1833 Category:Companies based in Irving, Texas Category:Companies listed on the New York Stock Exchange Category:Health care companies based in Texas Category:Multinational companies headquartered in the United States Category:Pharmaceutical companies of the United States